The Philadelphia-based insurer is the first Blue Cross Blue Shield plan to cover the ConfirmMDx for Prostate Cancer test.
“This positive coverage decision by Independence Blue Cross is a significant milestone as we work toward achieving nationwide payer adoption of our ConfirmMDx for Prostate Cancer test,” said Jan Groen, PhD, CEO of MDxHealth. “This decision demonstrates that our investment in clinical studies and our work with managed care organizations in the U.S. continues to yield positive results.”
More articles about payer issues:
BCBS of Texas commits to offering ACA plans for 2017
House will vote on ACA individual mandate exemption bill
Aetna looks toward social programs for healthcare reform
At the Becker's 5th Annual Fall Payer Issues Roundtable, taking place November 2–3 in Chicago, payer executives and healthcare leaders will come together to discuss value-based care, regulatory changes, cost management strategies and innovations shaping the future of payer-provider collaboration. Apply for complimentary registration now.
